You have a Sterility Failure or Bioburden Excursion - Now What?
| Date: | 04-Apr-12 to 04-Apr-12 |
| Location: | Online Webinar / California City / United States |
| Category: | Healthcare & Pharmaceuticals |
All sterile products require some level of sterility and bioburden testing during validation and then during routine production. What actions your company takes when this testing exhibits results that do not meet specifications can be critical from a regulatory and safety standpoint. You need to know what and how to investigate during these potential failures or out-of-specification conditions to identify the root cause. You also need to know if the failure impacts product release, do you need to recall product, is your validation okay, and are there any actions that can be taken to prove there is no product impact.
Areas Covered in the Seminar:
* Is this result really a failure that needs to be investigated?
* What items are important to investigate during sterilization process validation?
* If a failure occurs during sterilization process validation what actions can you take?
* The lab says the routine process BI is positive, what now?
* My dose audit did not pass, what does that mean?
* The periodic bioburden testing exceeded the established alert limit, what actions should be taken?
* What do you do if the bioburden action limit is exceeded?
* How to determine if the bioburden excursion has an impact to sterilization.
Visitors
* Validation specialists
* Manufacturing personnel involved in validations
* R&D specialists
Exhibitors
Enhancing global compliance, creating a world where quality and compliance professionals, regulators,and government agencies come together to help the world comply with the intent and the spirit of laws, policies and mandates, ensuring continuous improvement in global operations, quality & safety.
Making sure that we are responsible corporate citizens helping our constituents build a more responsible enterprise, one which operates with high quality , under a code of ethics, and with process discipline to ensure greater shareholder returns.
Keeping things simple and straight forward , so that we all can indeed improve the quality of our processes, our work, our businesses and enhance compliance globally.
Being inclusive, giving the process experts ( & novices! ), compliance professionals, quality champions, and regulatory agencies a voice so that all of us can contribute and make a difference.
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Dental Industry Today
- EIN News Report: GlaxoSmithKline
- EIN News Report: Merck
- EIN News Report: Pfizer
- H1N1 News Today
- Healthcare Industry Today
- Lung Cancer News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Prostate Cancer News Today
About